BOUT

Fund Description
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investors Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the securitys recent "resistance level", with consideration for various market conditions.
Fund Profile
Fund Name Innovator IBD Breakout Opportunities ETF
Fund Exchange Ticker BOUT
Fund Sponsor Innovator Management
Fund ISIN US45782C7636
Net Expense Ratio 0.80 %
Fund Inception Date 13 September 2018
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Passive
Index Name IBD Breakout Stocks Index
Index Provider IBD
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 May 2019
Asset Under Management 10.38 Million (USD)
1 Month Total Return 2.14 %
Year To Date Return 19.32 %
1 Year Total Return
3 Year Annualized Total Return
NAV 20.76
Share Outstanding 500,000
Top 10 Holdings (20 May 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
SILK ROAD MEDICAL INC SILK EQUI 0.0335000000
ENSIGN GROUP INC/THE ENSG EQUI 0.0334000000
HARRIS CORP HRS EQUI 0.0325000000
BLACKLINE INC BL EQUI 0.0324000000
Shockwave Medical Inc. SWAV EQUI 0.0324000000
NOVOCURE LTD NVCR EQUI 0.0319000000
JPMORGAN CHASE & CO JPM EQUI 0.0318000000
HANOVER INSURANCE GROUP INC/ THG EQUI 0.0316000000
FACTSET RESEARCH SYSTEMS INC FDS EQUI 0.0315000000
AARON'S INC AAN EQUI 0.0312000000